February 12, 2019 MEMPHIS, Tenn.–(BUSINESS WIRE)–Dr. Raymond Gardocki of the Campbell Clinic in Memphis, TN, performed his 100th endoscopic spine surgery on February 6, 2019, utilizing joimax® endoscopic spine technologies. By implementing joimax® endoscopic surgical systems into their center, Dr. Gardocki and the Campbell Clinic are on the forefront of minimally invasive spine surgery. “We are very excited …
All News
11 February 2019 | By Ana Mulero Australia’s Therapeutic Goods Administration (TGA) opened a consultation on Monday to obtain feedback on its proposal to reclassify all spinal implantable medical devices to a higher risk level. The consultation describes the reasoning behind changing the current Class IIb classification of medium-high risk on spinal implants to Class III …
BELGRADE, MT, Feb. 12, 2019 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the recent additions of five senior sales executives: Dana Lyons, Vice President of US Sales, Jamey Rottman, Regional Vice President, Mid Atlantic, Chris Cochran, …
FEB 08, 2019 / Susan Morse, Senior Editor Providers, payers, pharmacists, pharmacy benefit managers, drug manufacturers and consumers all have a stake in the recent proposal by the Department of Health and Human Services to lower the cost of prescription drugs by taking away kickback protections on rebates. Reaction to the proposal has varied. America’s Health Insurance Plans and pharmacy benefit managers …
KIRKLAND, QC, Feb. 11, 2019 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTi” or the “Company”), an emerging Orthopaedic and Sports Medicine Technology company, today announced the initiation of a 6-month pivotal animal study on Ortho-R for rotatorcuff repair. In addition, a pre-IND (Investigational New Drug) meeting is to be held later this month with the …
HOUSTON, Feb. 11, 2019 /PRNewswire/ — SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts (HDFs), today announced the issuance of a new patent in Canada. The patent adds to the company’s intellectual property portfolio with 37 U.S. and international patents issued with 100+ patents pending focused on fibroblast technologies. The …
SCHLIEREN (ZURICH), Switzerland, Feb. 11, 2019 (GLOBE NEWSWIRE) — Kuros Biosciences (SIX: KURN) today announced that its Dutch subsidiary, Kuros Biosciences BV, has signed a private label Original Equipment Manufacturer (OEM) agreement with SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders. Under the …
© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1